# Evaluation of the Risk of NSF Following ProHance Injection in Patients With Chronic Kidney Disease

> **NCT00600834** · — · COMPLETED · sponsor: **Bracco Diagnostics, Inc** · enrollment: 172 (actual)

## Conditions studied

- Renal Insufficiency

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00600834
- **Lead sponsor:** Bracco Diagnostics, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 172 (ACTUAL)
- **Last updated:** 2014-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00600834

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00600834, "Evaluation of the Risk of NSF Following ProHance Injection in Patients With Chronic Kidney Disease". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00600834. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*